Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

451 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Enrolling by invitation

Open-Label Extension Study to Pioneer Study 6058-SCD-101

NCT07401823

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Our Lady of the Lake Hospital Baton Rouge, Louisiana, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Enrolling by invitation

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

NCT05768386

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Orthopedic Institute for Children, Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
  • University of California San Diego, Hemophilia & Thrombosis Treatment Center San Diego, California, United States
  • University of California San Francisco - Moffit Hospital, Outpatient Hematology Clinic San Francisco, California, United States
View all 41 locations
View Trial Details
Enrolling by invitation

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

NCT06363760

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

NCT06684314

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Investigational Site Number : 1580008 Changhua, Taiwan
  • Investigational Site Number : 1580001 Taipei, Taiwan
  • Investigational Site Number : 1580002 Taipei, Taiwan
  • Investigational Site Number : 1580009 Kaohsiung City, Taiwan
View Trial Details
Active, not recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • California Research Institute Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Oncology-Hematology Associates of West Broward Coral Springs, Florida, United States
  • New Jersey Center for Cancer Research Brick, New Jersey, United States
View all 108 locations
View Trial Details
Active, not recruiting

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

NCT04662255

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Arizona Oncology Associates, P.C. - HOPE Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • USO-Rocky Mountain Cancer Center Denver, Colorado, United States
View all 189 locations
View Trial Details

Related conditions